Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01371877 · ClinicalTrials.gov registry record · NA
The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT01371877 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 42 participants.
The verdict
NCT01371877, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
This clinical study was designed based on our hypothesis that vitamin D plays an important role in chronic urticaria and that high dose supplementation with vitamin D in subjects with chronic urticaria will improve clinical response. This clinical study will investigate our hypothesis in three Specific Aims: 1. Determine whether high dosing vitamin D supplementation (4000 IU/day) reduces medication usage (primary outcome) and urticaria severity score (secondary outcome) in subjects with chronic urticaria as compared to low dosing (600 IU/day). 2. Determine if high dosing of vitamin D (4000 IU/day) is safe and well-tolerated in subjects with chronic urticaria with or without baseline vitamin D deficiency. 3. Investigate whether there is an association with serum 25-hydroxyvitamin D levels, vitamin D receptor mRNA expression, and chronic urticaria severity.
Interventions
- DRUG High Dose Vitamin D3
- DRUG Low Dose Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2011-11-01 |
| Est. Completion | 2013-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01371877
The ClinicalTrials.gov registry entry for NCT01371877 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High Dose Vitamin D3 is the first listed.
NCT01371877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01371877 about?
NCT01371877 is a clinical study titled "The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment". This clinical study was designed based on our hypothesis that vitamin D plays an important role in chronic urticaria and that high dose supplementation with vitamin D in subjects with chronic urticaria will improve clinical response. This clinical study will investigate our hypothesis in three Spec...
What is the current status of trial NCT01371877?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2011-11-01. Estimated completion is 2013-09-01.
What interventions are being tested in trial NCT01371877?
The interventions under investigation include: High Dose Vitamin D3 (DRUG), Low Dose Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT01371877?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.